Skip to search formSkip to main contentSkip to account menu

esaprazole

Known as: N-((N-cyclohexylcarbamoyl)methyl)piperazine, hexaprazol 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Piperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Esaprazole: offers no significant advantage over cimetidine in the treatment of gastric ulcer
1989
1989
Gastrointestinal hormones and serum group I pepsinogen after intravenous hexaprazol injection in healthy volunteers
Thirteen healthy control subjects were studied in order to evaluate any effect of acute hexaprazol injection on some… 
1989
1989
Esaprazole versus pirenzepine in chronic congestive gastritis: a double-blind clinical endoscopic and functional study
1987
1987
Effect of esaprazole on sham-feeding-stimulated and pentagastrin-stimulated acid secretion in humans
1987
1987
Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
The antisecretory effects of esaprazole on basal gastric secretion and on pentagastrin-stimulated secretion (6 micrograms/kg… 
1985
1985
Hexaprazol antagonism to gastric electrical potential fall by acetylsalicylic acid in rat.
Hexaprazol was tested against the gastric barrier breaking effect of aspirin (ASA), using the electric potential difference (PD… 
1984
1984
Hexaprazol: a new antiulcer drug with a cytoprotective action.
1984
1984
Metabolites of esaprazole in rat, dog and human urine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)